The CMS decision to cover renal denervation for uncontrolled hypertension may help overcome current hesitation about use of ...

The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...

On February 13-14, 2023, the Centers for Medicare & Medicaid Services (CMS) convened a virtual panel of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) to evaluate changes to ...

White Paper How to Outsmart the AI Bot Boom A practical framework for keeping your healthcare site secure, performant and visible, even as AI traffic explodes Read now On-Demand Webinar How to Build ...

On January 11, 2022, the Centers for Medicare and Medicaid Services (“CMS”) published an anticipated proposed National Coverage Determination (“NCD”) decision memorandum that begins the process of ...

The Centers for Medicare & Medicaid Services (CMS) has announced a competition to develop artificial intelligence (AI) solutions that can better predict health outcomes, such as adverse events and ...